podcasts Ratings /ratings/en/research-insights/podcasts/2020-02-11-sp-pharma-dose-episode-34-more-color-on-ppd-s-rating-after-ipo content esgSubNav
In This List

S&P Pharma Dose - Episode 34: More Color on PPD’s Rating After IPO

COMMENTS

A Sudden Correction To Fast-Rising U.S. Home Prices Isn't Likely

COMMENTS

COVID-19 Impact: Key Takeaways From Our Articles

RESUPD

Research Update: Australian Postal Corp. Outlook Revised To Stable On Strong Parcel Earnings; 'A+/A-1' Ratings Affirmed

What's It Worth? The Rise Of Electric Vehicles In European Auto ABS

Listen: S&P Pharma Dose - Episode 34: More Color on PPD’s Rating After IPO

In this episode of S&P Pharma Dose, senior healthcare analyst Ji Liu discusses his view on Pharmaceutical Product Development LLC (PPD) after its recent IPO on Feb. 5, 2020.

Register with S&P Global Ratings

Register now to access exclusive content, events, tools, and more.

Go Back